DeepCyto
PrivateLast Round
Series B
Nov 17, 2022
Est. Valuation
$48.5M
Total Funding Raised
$17.2M
Company Overview
DeepCyto is a medical technology company that provides AI-powered medical diagnosis and healthcare data analysis solutions for blood diseases.
Sector
Healthcare & Life Sciences
Verticals
Medical Imaging, Medical Devices, Medical AI, Biotech Equipment
Business Model
B2B
Customer Profile
Hardware Sales, Subscription SaaS, Services & Consulting
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
DeepCyto Comparables
Compare DeepCyto with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Hangzhou Zhiwei Information Technology Co., Ltd. | 84% | |
| SigTuple | 80% | |
| Scopio Labs | 80% |
DeepCyto Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series B | Nov 17, 2022 | ||||
| Series A | Nov 1, 2021 | ||||
| Series A | Nov 19, 2020 | ||||
| Seed | May 28, 2018 |
DeepCyto Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Breyer Capital | Seed |
| Fusion Fund | Series B, Seed, Series A |
| Nina Capital | Series A |
| Bencao Capital | Series A |
| ZhenFund | Seed |
| Baidu Ventures | Seed |
| Northern Light Venture Capital | Series A, Pre Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Nov 17, 2022
Led by Primavera Venture Partners and Eastern Bell Capital.
- Nov 1, 2021
Closed Series A at $48.5M post-money valuation.
DeepCyto Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about DeepCyto's valuation, stock price, and market status.
Is DeepCyto a public or private company?
DeepCyto is a private company.
What is the current stock price of DeepCyto?
DeepCyto is a private company with no public stock price. No recent secondary market data is available.
How much is DeepCyto worth (valuation)?
DeepCyto's valuation is estimated at $48.5M based on funding round data.
Can I buy DeepCyto stock?
DeepCyto shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was DeepCyto's last funding round?
DeepCyto's most recent funding round was Series B on November 1, 2021.
Who are the main investors in DeepCyto?
Key investors in DeepCyto include Bencao Capital, Northern Light Venture Capital, Bessemer Venture Partners, Primavera Venture Partners, Eastern Bell Capital.
Will DeepCyto IPO soon?
No public IPO plans have been announced for DeepCyto.
How can I track DeepCyto secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor DeepCyto's secondary market activity and sign up for updates.